Implementing a pharmacogenomic-driven algorithm to guide antiplatelet therapy among Caribbean Hispanics: a non-randomised clinical trial.
Hector J Nuñez-MedinaMariangeli MoneroLorna M TorresEnrique LealLorena Gonzalez-SepulvedaÁngel M MayorJessicca Y RentaEdgardo R González-GarcíaAriel GonzálezKyle R MelinStuart A ScottGualberto RuañoDagmar F Hernandez-SuarezJorge DucongePublished in: BMJ open (2024)
NCT03419325.
Keyphrases
- antiplatelet therapy
- clinical trial
- acute coronary syndrome
- percutaneous coronary intervention
- open label
- double blind
- machine learning
- deep learning
- phase ii
- quality improvement
- clinical decision support
- study protocol
- phase iii
- neural network
- placebo controlled
- coronary artery disease
- randomized controlled trial
- atrial fibrillation